Insmed Inc (INSM)

Sep 30, 2025

Insmed: De-Risked Respiratory Growth, Premium Multiple, And Real M&A Optionality - Seeking Alpha

Sep 30, 2025

Sep 30, 2025

Insmed Incorporated (INSM) Rallies After FDA Approves Brinsupri, Shares Jump 9% - Yahoo Finance

Sep 30, 2025

Sep 30, 2025

S&P 500 Futures Decline in Premarket Trading; Firefly Aerospace, Insmed Lag - Barron's

Sep 30, 2025

Sep 29, 2025

Real time breakdown of Insmed Incorporated stock performanceQuarterly Profit Review & Low Risk Entry Point Guides - newser.com

Sep 29, 2025

Sep 29, 2025

How buyback programs support Insmed Incorporated (IM8N) stockShort Setup & AI Enhanced Trade Execution Alerts - newser.com

Sep 29, 2025

Sep 29, 2025

Public Employees Retirement System of Ohio Makes New Investment in Insmed, Inc. $INSM - MarketBeat

Sep 29, 2025

Sep 28, 2025

Goldman's 48 potential M&A candidates (INSM:NASDAQ) - Seeking Alpha

Sep 28, 2025

Sep 28, 2025

Is Insmed Incorporated a good long term investmentSector Performance Review & Build Winning Portfolio - earlytimes.in

Sep 28, 2025

Sep 28, 2025

Insmed Incorporated Stock Analysis and ForecastInsider Trading Compliance & Access Free Tools and Start Investing - Early Times

Sep 28, 2025

Sep 27, 2025

RBC Capital Remains Bullish on Insmed Incorporated (INSM) - Yahoo Finance

Sep 27, 2025

Sep 26, 2025

How Insmed Incorporated (IM8N) stock performs during market turbulenceDividend Hike & Daily Volume Surge Trade Alerts - newser.com

Sep 26, 2025

Sep 24, 2025

Assenagon Asset Management S.A. Buys 33,626 Shares of Insmed, Inc. $INSM - MarketBeat

Sep 24, 2025

Sep 22, 2025

Longboard Asset Management LP Acquires New Position in Insmed, Inc. $INSM - MarketBeat

Sep 22, 2025

Sep 22, 2025

Insmed Incorporated to Present Multiple Abstracts At the European Respiratory Society Congress 2025 - MarketScreener

Sep 22, 2025

Sep 22, 2025

Cystic Fibrosis Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Insmed Inc, AstraZeneca, Zambon, CSL Behring, Chiesi Farmaceutici - The Globe and Mail

Sep 22, 2025

Sep 22, 2025

Insmed to Present Phase 2b TPIP and Phase 3 ASPEN Trial Data at ERS Congress 2025 - geneonline.com

Sep 22, 2025

Sep 22, 2025

Insmed (INSM) Highlights Phase 2 and Phase 3 Trial Data at ERS 2025 Congress - GuruFocus

Sep 22, 2025

Sep 22, 2025

Insmed to Present Multiple Abstracts at the European Respiratory Society Congress 2025 - PR Newswire

Sep 22, 2025

Sep 22, 2025

Harbor Capital Advisors Inc. Sells 26,030 Shares of Insmed, Inc. $INSM - MarketBeat

Sep 22, 2025

Sep 22, 2025

Financiere des Professionnels Fonds d investissement inc. Makes New $452,000 Investment in Insmed, Inc. $INSM - MarketBeat

Sep 22, 2025

Sep 22, 2025

Late-Breaking PAH Treatment Data: Insmed's TPIP Phase 2b Results Lead 7 Presentations at ERS Congress 2025 - Stock Titan

Sep 22, 2025

Sep 21, 2025

Weekly Trades: Will Insmed Incorporated outperform its industry peersMarket Activity Report & Risk Controlled Daily Plans - خودرو بانک

Sep 21, 2025

Sep 21, 2025

Strs Ohio Purchases Shares of 25,700 Insmed, Inc. $INSM - MarketBeat

Sep 21, 2025

Sep 21, 2025

Dividend Watch: Whats the beta of Insmed Incorporated stockMarket Trend Summary & Precise Swing Trade Alerts - خودرو بانک

Sep 21, 2025

Sep 21, 2025

Rep. Gilbert Ray Cisneros, Jr. Sells Insmed, Inc. (NASDAQ:INSM) Shares - MarketBeat

Sep 21, 2025

Sep 20, 2025

Signal Recap: Is Insmed Incorporated stock good for income investorsWeekly Volume Report & Precise Swing Trade Entry Alerts - khodrobank.com

Sep 20, 2025

Sep 20, 2025

Is Insmed Incorporated stock a smart retirement pick2025 Price Momentum & AI Powered Buy/Sell Recommendations - khodrobank.com

Sep 20, 2025

Sep 20, 2025

Insmed (NASDAQ:INSM) Insider Orlov S. Nicole Schaeffer Sells 76,520 Shares - MarketBeat

Sep 20, 2025

Sep 20, 2025

Melvin Md Sharoky Sells 10,000 Shares of Insmed (NASDAQ:INSM) Stock - MarketBeat

Sep 20, 2025

Sep 20, 2025

Insmed, Inc. $INSM Shares Bought by UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC - MarketBeat

Sep 20, 2025